Abstract:BACKGROUND:Despite recent reforms, distorting funding mechanisms and over-prescribing still maintain severe financial barriers to medicines access in China. Complicated and interrelated problems in the pharmaceutical sector require a common framework to be resolved as fragmented solutions do not work. We present a preliminary assessment of the impact of the national healthcare reforms on access to medicines, and propose policy recommendations for promoting universal access to medicines in China.METHODS:Drawing on multiple sources of information, including a review of published literatures and official national data, field investigations in six provinces and interviews with key opinion leaders, this paper presents a preliminary assessment of the impact of the national healthcare reforms on access to medicines, and proposes policy recommendations for promoting universal access to medicines in China.RESULTS:Public expenditure on medicines has been strictly controlled since the national healthcare reforms of 2009. Yet total pharmaceutical expenditure (TPE) and total health expenditure growth rates continuously outpaced the growth of gross domestic product (GDP). With 2.4% of GDP, TPE now exceeds that of most high income countries. The distorted provider and consumer incentives in the Chinese health system have not fundamentally changed. Price-setting and reimbursement mechanisms do not promote cost-effective use of medicines. Inappropriate price controls and perverse financial incentives are the un-resolved root causes of preference of originator brands for some major diseases and shortages of low-cost and low-consumption medicines. In addition, access to expensive life-saving medicines is yet systematically addressed.CONCLUSIONS:The complicated and interdependent problems interact in a way that leads to significant system problems in China, which create dual challenges that both the developing country and the developed countries are facing. To further promote access to medicines, China should speed up the re-assessment of the quality and efficacy of domestically produced generic medicines; coordinate various reforms of price determination, insurance payments, and procurement policies; address medicine shortages through comprehensive policies and legislation; establish specific mechanisms to achieve sustainable equitable access to expensive essential medicines with health technology assessment as a tool to ensure that policy and priority setting are created in a coherent and evidence-based way.

Review 3 of Opinions of China Medical Reform Draft Plan:The Trend of Medicine Reform is One of the Controversies

Review 2 of Opinions of China Medical Reform Draft Plan: the State-Owned Medical Institution Reform is the Emphasis and the Main Difficulty

Review 1 of opinions of China medical reform draft plan: to nail down the government's financing function is the crucial key of the medical reform

Effective Chinese Medical Reform Mode :Starting from Compensation Mechanism Reform

A Review of China’s Health Care Reform After the Reform and Open Policy in 1978

On China's Medical System Reform

Health System Reform in Rural China: Voices of Healthworkers and Service-Users.

Early appraisal of China's huge and complex health-care reforms

The Base and Near Aim of Medical Reform: to Solve the Problem That the Patients and Doctors Complain of and the Media Focus On

Policy Review and Problem Analysis of Major Medical Equipment (class B) Allocation and Management in China

China's Health Care System Reform: Progress and Prospects.

Evaluating Three-year Health Care Reform

THE PUBLIC HOSPITAL REFORM AND DEVELOPMENT UNDER THE BACKGROUND OF NEW REFORM

Essential medicines system reform in China:Achievements and challenges

Review and analysis of focused problems of public hospital reform in China

A Review of Promoting Access to Medicines in China - Problems and Recommendations.

Discussions on the Progress and Problems of Public Hospital Payment System Reforms in China

Price Controls of Health Service and the System of Underpaid Doctors Compensated by the Excessive Medical Expense

“Drug Rebate” Is the Crux of the Problem of Health Care Reform in China

Essential medicine policy in China: pros and cons.

The health reform activities will not work under the existing reimbursement mechanism